395938000: Clavulanate potassium (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Substance with beta-lactamase inhibitor mechanism of action\Clavulanate potassium (substance)
\Substance categorized by disposition\Antibacterial\Substance with beta-lactam structure and antibacterial mechanism of action (substance)\Clavulanate potassium (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antibacterial\Substance with beta-lactam structure and antibacterial mechanism of action (substance)\Clavulanate potassium (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Amide\Lactam\Beta-lactam (substance)\Substance with beta-lactam structure and antibacterial mechanism of action (substance)\Clavulanate potassium (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Lactam\Beta-lactam (substance)\Substance with beta-lactam structure and antibacterial mechanism of action (substance)\Clavulanate potassium (substance)
\Organic compound\Organic cyclic compound\Heterocyclic compound\Azetidine derivative (substance)\Beta-lactam (substance)\Substance with beta-lactam structure and antibacterial mechanism of action (substance)\Clavulanate potassium (substance)
\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Amide\Lactam\Beta-lactam (substance)\Substance with beta-lactam structure and antibacterial mechanism of action (substance)\Clavulanate potassium (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1469878017 Clavulanate potassium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1489570012 Clavulanate potassium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

2694206012 Potassium clavulanate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

18241000188119 potassium clavulanate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Clavulanate potassium (substance)	Is a	Clavulanate	false	Inferred relationship	Some
Clavulanate potassium (substance)	Is a	Clavulanic acid (substance)	false	Inferred relationship	Some
Clavulanate potassium (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Clavulanic acid (substance)	true	Inferred relationship	Some
Clavulanate potassium (substance)	Is a	Substance with beta-lactam structure and antibacterial mechanism of action (substance)	true	Inferred relationship	Some
Clavulanate potassium (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antibacterial (disposition)	true	Inferred relationship	Some
Clavulanate potassium (substance)	Is a	Enzyme inhibitor	false	Inferred relationship	Some
Clavulanate potassium (substance)	Is a	Substance with beta-lactamase inhibitor mechanism of action	true	Inferred relationship	Some
Clavulanate potassium (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Beta-lactamase inhibitor	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Amoxicillin + clavulanate potassium adverse reaction	Causative agent (attribute)	False	Clavulanate potassium (substance)	Inferred relationship	Some	2
Allergy to amoxicillin and clavulanate potassium	Causative agent (attribute)	False	Clavulanate potassium (substance)	Inferred relationship	Some
Amoxicillin + clavulanate potassium 125mg/31mg/5mL s/f suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Amoxicillin 500 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Amoxicillin + clavulanate potassium 400mg/57mg/5mL s/f suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Amoxicillin + clavulanate potassium 250mg/125mg s/f dispersible tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Amoxicillin (as amoxicillin sodium) 1 g and clavulanic acid (as clavulanate potassium) 200 mg powder for solution for injection vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Amoxicillin + clavulanate potassium 250mg/62.5mg/5mL s/f suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
médicament contenant amoxicilline et acide clavulanique	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Amoxicillin 800 mg and clavulanate potassium 125 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Amoxicillin + clavulanate potassium 200mg/28.5mg chewable tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Amoxicillin + clavulanate potassium 250mg/62.5mg chewable tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Amoxicillin + clavulanate potassium 400mg/57mg chewable tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Amoxicillin + clavulanate potassium 200mg/28.5mg/5mL s/f suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Product containing precisely amoxicillin (as amoxicillin trihydrate) 80 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 11.4 milligram/1 milliliter conventional release oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Product containing amoxicillin and clavulanate potassium in oral dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Product containing amoxicillin and clavulanate potassium in parenteral dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Product containing precisely amoxicillin 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Amoxicillin + clavulanate potassium 600mg/42.9mg/5mL s/f suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Product containing clavulanate potassium	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Ticarcillin + clavulanate potassium	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Amoxicillin + clavulanate potassium 1g/62.5mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Amoxicillin + clavulanate potassium 200mg/28.5mg/5mL oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Allergy to amoxicillin and clavulanate potassium	Causative agent (attribute)	False	Clavulanate potassium (substance)	Inferred relationship	Some	2
Amoxicillin 500 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some	1
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some	1
Amoxicillin 800 mg and clavulanate potassium 125 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some	2
Amoxicillin 800 mg and clavulanate potassium 125 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Product containing precisely amoxicillin 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some	1
Amoxicillin + clavulanate potassium 1g/62.5mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Amoxicillin + clavulanate potassium 250mg/125mg tablet for conventional release oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Amoxicillin + clavulanate potassium 600mg/42.9mg/5mL conventional release oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clavulanate potassium (substance)	Inferred relationship	Some
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Amoxicillin 500 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Clavulanate potassium (substance)	Inferred relationship	Some	1
Product containing precisely amoxicillin 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Amoxicillin 800 mg and clavulanate potassium 125 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Clavulanate potassium (substance)	Inferred relationship	Some	1
Amoxicillin (as amoxicillin sodium) 1 g and clavulanic acid (as clavulanate potassium) 200 mg powder for solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Product containing precisely amoxicillin (as amoxicillin trihydrate) 50 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 12.5 milligram/1 milliliter conventional release oral suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Clavulanate potassium (substance)	Inferred relationship	Some	2
Product containing precisely amoxicillin (as amoxicillin trihydrate) 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Clavulanate potassium (substance)	Inferred relationship	Some	1
Product containing precisely clavulanic acid (as clavulanate potassium) 200 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Product containing precisely amoxicillin (as amoxicillin trihydrate) 80 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 11.4 milligram/1 milliliter conventional release oral suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Clavulanate potassium (substance)	Inferred relationship	Some	2
Product containing precisely amoxicillin (as amoxicillin trihydrate) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Clavulanate potassium (substance)	Inferred relationship	Some	2
Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Product containing precisely amoxicillin anhydrous (as amoxicillin) 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Clavulanate potassium (substance)	Inferred relationship	Some	1
Product containing precisely clavulanic acid (as clavulanate potassium) 1 milligram and ticarcillin (as ticarcillin disodium) 30 milligram/1 vial powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Clavulanate potassium (substance)	Inferred relationship	Some	2
Product containing precisely amoxicillin anhydrous (as amoxicillin) 120 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 8.58 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Clavulanate potassium (substance)	Inferred relationship	Some	1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 250 milligram and clavulanic acid (as clavulanate potassium) 62.5 milligram/1 each conventional release chewable tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Clavulanate potassium (substance)	Inferred relationship	Some	1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release chewable tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Clavulanate potassium (substance)	Inferred relationship	Some	1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Clavulanate potassium (substance)	Inferred relationship	Some	1
Product containing precisely amoxicillin (as amoxicillin trihydrate) 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Clavulanate potassium (substance)	Inferred relationship	Some	2
Product containing precisely amoxicillin (as amoxicillin trihydrate) 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Clavulanate potassium (substance)	Inferred relationship	Some	2
Product containing precisely amoxicillin 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Amoxicillin 500 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Product containing precisely amoxicillin 80 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 11.4 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Product containing precisely amoxicillin 50 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 12.5 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Amoxicillin 400 mg and clavulanic acid (as clavulanate potassium) 57 mg chewable tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Product containing precisely amoxicillin 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Product containing precisely amoxicillin 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Amoxicillin 120 mg/mL and clavulanic acid (as clavulanate potassium) 8.58 mg/mL oral suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Amoxicillin (as amoxicillin sodium) 250 mg and clavulanic acid (as clavulanate potassium) 50 mg powder for solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Product containing precisely cefuroxime (as cefuroxime axetil) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Product containing precisely amoxicillin 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Product containing precisely amoxicillin 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 50 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clavulanate potassium (substance)	Inferred relationship	Some	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1469878017	Clavulanate potassium (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1489570012	Clavulanate potassium	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2694206012	Potassium clavulanate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
18241000188119	potassium clavulanate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module